Downregulates bcl-2 expression and upregulating Bax and p53 to inhibit tumorigenesis in lung, ovarian and colon cancer cells. Downregulates MMP-2 and E-cadherin expression along with platelet activation resulting in reduced invasion of hepatic adenocarcinoma cell line. Here, TP53 is linked to colonic neoplasm.